Supreme Court asks drugs advisory body to decide fate of over 334 banned combination medicines
Companies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates on the issue.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news